Ping Hai

机构：Ningxia Medical University, Ningxia Medical University General Hospital · ORCID：0000-0001-9528-1308

发表论文 34 篇 · 总被引 259 次 · h-index 10

代表论文

• Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction (2023 · European Journal of Medicinal Chemistry · 被引 26)
• Combining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma Patients (2017 · BioMed Research International · 被引 24)
• Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy (2017 · Oncotarget · 被引 23)
• ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma (2012 · Radiation Oncology · 被引 23)
• Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy (2016 · Disease Markers · 被引 21)
• All-in-one nanotheranostic platform based on tumor microenvironment: new strategies in multimodal imaging and therapeutic protocol (2024 · Drug Discovery Today · 被引 13)